Newsfeeds Archive - Page 9 of 11

2 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Friday, December 30, 2022: AMD, T, TDG, KALA, TGTX

December 30, 10:15 AM

Advanced Micro Devices (AMD) - The 2023 Consumer Electronics Show (CES) will kick off next week. Long-time keynote speaker, Lisa Su, AMD's CEO, will present on Wednesday, January 4 around 6:30

AMD

1 minute read

Goldman Sachs Maintains Sell on TG Therapeutics, Raises Price Target to $6

By Benzinga Newsdesk

December 30, 9:16 AM

Goldman Sachs analyst Corinne Jenkins maintains TG Therapeutics (NASDAQ:TGTX) with a Sell and raises the price target from $4 to $6.

TGTX

1 minute read

Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session

By Lisa Levin

December 30, 8:52 AM

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

BORR

1 minute read

B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $23

By Benzinga Newsdesk

December 30, 5:46 AM

B. Riley Securities analyst Mayank Mamtani maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $17 to $23.

TGTX

1 minute read

Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets

By Vandana Singh

December 29, 3:47 PM

Wednesday, the FDA approved TG Therapeutics Inc's (NASDAQ: TGTX) Briumvi (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS).

TGTX

4 minute read

Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

December 29, 2:14 PM

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.

AFRM

1 minute read

Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here’s What You Need To Know

By Benzinga Insights

December 29, 1:01 PM

HC Wainwright & Co. has decided to maintain its Buy rating of TG Therapeutics (NASDAQ:TGTX) and raise its…

TGTX

1 minute read

What’s Going On With TG Therapeutics Shares

By Henry Khederian

December 29, 10:54 AM

TG Therapeutics Inc (NASDAQ: TGTX) shares are trading higher by 9.34% to $9.25 Thursday morning. The company on Wednesday revealed FDA approval of ublituximab. What's Happening?

TGTX

2 minute read

Tesla To $250? Here Are 10 Other Price Target Changes For Thursday

By Lisa Levin

December 29, 10:09 AM

Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in pre-market trading.

AJG